Shopping Cart
Remove All
Your shopping cart is currently empty
GNE-0723 is a selective positive allosteric modulator of the NMDA receptor, with an EC50 of 21 nM for GluN2A. It can cross the blood-brain barrier (BBB) and improve outcomes in Dravet syndrome (DS) and Alzheimer's disease (AD).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $457 | - | In Stock | |
| 5 mg | $1,060 | - | In Stock | |
| 10 mg | $1,420 | - | In Stock | |
| 25 mg | $2,120 | - | In Stock | |
| 50 mg | $2,780 | - | In Stock |
| Description | GNE-0723 is a selective positive allosteric modulator of the NMDA receptor, with an EC50 of 21 nM for GluN2A. It can cross the blood-brain barrier (BBB) and improve outcomes in Dravet syndrome (DS) and Alzheimer's disease (AD). |
| Targets&IC50 | GluN2C:7.4 μM(EC50), GluN2D:6.2 μM(EC50), GluN2A:21 nM (EC50) |
| In vitro | GNE-0723 is a brain-permeable NMDAR positive allosteric modulator with EC50 of 21 nM/7.4μM/6.2 μM for GluN2A/2C/2D. [1] |
| Synonyms | GNE0723 |
| Molecular Weight | 467.78 |
| Formula | C16H8ClF6N5OS |
| Cas No. | 1883518-31-7 |
| Smiles | C(F)(F)(F)C1=C(N2C(S1)=NC(CN3N=C(C(F)(F)F)C=C3Cl)=CC2=O)[C@H]4[C@H](C#N)C4 |
| Relative Density. | 1.84 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 160 mg/mL (342.04 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.